3IEJ
Pyrazole-based Cathepsin S Inhibitors with Arylalkynes as P1 Binding Elements
Summary for 3IEJ
Entry DOI | 10.2210/pdb3iej/pdb |
Descriptor | Cathepsin S, 2-[3-{4-chloro-3-[(4-chlorophenyl)ethynyl]phenyl}-1-(3-morpholin-4-ylpropyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl]-2-oxoethanol (3 entities in total) |
Functional Keywords | cathepsin s, disulfide bond, glycoprotein, hydrolase, lysosome, polymorphism, protease, thiol protease, zymogen |
Biological source | Homo sapiens (human) |
Cellular location | Lysosome: P25774 |
Total number of polymer chains | 2 |
Total formula weight | 49969.69 |
Authors | Bembenek, S. (deposition date: 2009-07-22, release date: 2009-10-06, Last modification date: 2021-10-13) |
Primary citation | Ameriks, M.K.,Axe, F.U.,Bembenek, S.D.,Edwards, J.P.,Gu, Y.,Karlsson, L.,Randal, M.,Sun, S.,Thurmond, R.L.,Zhu, J. Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements. Bioorg.Med.Chem.Lett., 19:6131-6134, 2009 Cited by PubMed: 19773165DOI: 10.1016/j.bmcl.2009.09.014 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.18 Å) |
Structure validation
Download full validation report